UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005047
Receipt number R000006002
Scientific Title Effect of evening regimen on blood pressure control in patients with morning hypertension
Date of disclosure of the study information 2011/02/08
Last modified on 2011/02/08 14:40:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of evening regimen on blood pressure control in patients with morning hypertension

Acronym

Effect of evening regimen on blood pressure control in patients with morning hypertension

Scientific Title

Effect of evening regimen on blood pressure control in patients with morning hypertension

Scientific Title:Acronym

Effect of evening regimen on blood pressure control in patients with morning hypertension

Region

Japan


Condition

Condition

Hypertension

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The study was conducted to evaluate clinically effective treatment of morning hypertension

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Blood pressure(On visit/Home monitoring)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

In the combination therapy, either CCB or ARB was chosen. The administration after breakfast was changed into that at bedtime. Three months. Seventy patients.

Interventions/Control_2

In the combination therapy, either CCB or ARB was chosen. The administration after breakfast was changed. The dose was unchanged and given twice a day, i.e., after breakfast and at bedtime.Three months. Seventy patients.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The subjects were patients aged 40 years or older with hypertension. They were treated with CCB or ARB monotherapy or combination therapy with agents including CCB and ARB for at least 4 weeks and in whom the mean morning blood pressure at home for 5 days of one week prior to enrollment was 135/85 mmHg or higher.

Key exclusion criteria

The exclusion criteria were apparently poor control of blood pressure, secondary hypertension, difficulty in walking by oneself, hemodialysis, malignant disorder and pregnancy.

Target sample size

140


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Katsuji Imai

Organization

Imai Heart Clinic

Division name

Director

Zip code


Address

AminasuKitanoda204-1, 1077,Kitanoda, Higashi-ku, Sakai-shi, Osaka, Japan

TEL

072-235-4401

Email



Public contact

Name of contact person

1st name
Middle name
Last name Katsuji Imai

Organization

Imai Heart Clinic

Division name

Director

Zip code


Address

AminasuKitanoda204-1, 1077,Kitanoda, Higashi-ku, Sakai-shi, Osaka, Japan

TEL

072-235-4401

Homepage URL


Email

imai-hc@umin.ac.jp


Sponsor or person

Institute

Sakai Cardiovascular Clinical Conference

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 02 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2010 Year 10 Month 15 Day

Date of IRB


Anticipated trial start date

2010 Year 11 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 02 Month 08 Day

Last modified on

2011 Year 02 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006002


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name